172 related articles for article (PubMed ID: 22309224)
1. Spinocerebellar ataxia type 1 (SCA1): new pathoanatomical and clinico-pathological insights.
Rüb U; Bürk K; Timmann D; den Dunnen W; Seidel K; Farrag K; Brunt E; Heinsen H; Egensperger R; Bornemann A; Schwarzacher S; Korf HW; Schöls L; Bohl J; Deller T
Neuropathol Appl Neurobiol; 2012 Dec; 38(7):665-80. PubMed ID: 22309224
[TBL] [Abstract][Full Text] [Related]
2. Spinocerebellar ataxia type 6 (SCA6): neurodegeneration goes beyond the known brain predilection sites.
Gierga K; Schelhaas HJ; Brunt ER; Seidel K; Scherzed W; Egensperger R; de Vos RA; den Dunnen W; Ippel PF; Petrasch-Parwez E; Deller T; Schöls L; Rüb U
Neuropathol Appl Neurobiol; 2009 Oct; 35(5):515-27. PubMed ID: 19207264
[TBL] [Abstract][Full Text] [Related]
3. Degeneration of ingestion-related brainstem nuclei in spinocerebellar ataxia type 2, 3, 6 and 7.
Rüb U; Brunt ER; Petrasch-Parwez E; Schöls L; Theegarten D; Auburger G; Seidel K; Schultz C; Gierga K; Paulson H; van Broeckhoven C; Deller T; de Vos RA
Neuropathol Appl Neurobiol; 2006 Dec; 32(6):635-49. PubMed ID: 17083478
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the auditory brainstem system in spinocerebellar ataxia type 2 (SCA2), type 3 (SCA3) and type 7 (SCA7).
Hoche F; Seidel K; Brunt ER; Auburger G; Schöls L; Bürk K; de Vos RA; den Dunnen W; Bechmann I; Egensperger R; Van Broeckhoven C; Gierga K; Deller T; Rüb U
Neuropathol Appl Neurobiol; 2008 Oct; 34(5):479-91. PubMed ID: 18221259
[TBL] [Abstract][Full Text] [Related]
5. Spinocerebellar ataxia type 7 (SCA7): widespread brain damage in an adult-onset patient with progressive visual impairments in comparison with an adult-onset patient without visual impairments.
Rüb U; Brunt ER; Seidel K; Gierga K; Mooy CM; Kettner M; Van Broeckhoven C; Bechmann I; La Spada AR; Schöls L; den Dunnen W; de Vos RA; Deller T
Neuropathol Appl Neurobiol; 2008 Apr; 34(2):155-68. PubMed ID: 17971076
[TBL] [Abstract][Full Text] [Related]
6. ADC mapping of neurodegeneration in the brainstem and cerebellum of patients with progressive ataxias.
Della Nave R; Foresti S; Tessa C; Moretti M; Ginestroni A; Gavazzi C; Guerrini L; Salvi F; Piacentini S; Mascalchi M
Neuroimage; 2004 Jun; 22(2):698-705. PubMed ID: 15193598
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the cholinergic basal forebrain nuclei in spinocerebellar ataxia type 2 (SCA2).
Rüb U; Farrag K; Seidel K; Brunt ER; Heinsen H; Bürk K; Melegh B; von Gall C; Auburger G; Bohl J; Korf HW; Hoche F; den Dunnen W
Neuropathol Appl Neurobiol; 2013 Oct; 39(6):634-43. PubMed ID: 23363055
[TBL] [Abstract][Full Text] [Related]
8. Spinocerebellar ataxia type 4 (SCA4): Initial pathoanatomical study reveals widespread cerebellar and brainstem degeneration.
Hellenbroich Y; Gierga K; Reusche E; Schwinger E; Deller T; de Vos RA; Zühlke C; Rüb U
J Neural Transm (Vienna); 2006 Jul; 113(7):829-43. PubMed ID: 16362839
[TBL] [Abstract][Full Text] [Related]
9. Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7.
Rüb U; Schöls L; Paulson H; Auburger G; Kermer P; Jen JC; Seidel K; Korf HW; Deller T
Prog Neurobiol; 2013 May; 104():38-66. PubMed ID: 23438480
[TBL] [Abstract][Full Text] [Related]
10. Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics.
Della Nave R; Ginestroni A; Tessa C; Salvatore E; De Grandis D; Plasmati R; Salvi F; De Michele G; Dotti MT; Piacentini S; Mascalchi M
Neuroimage; 2008 Oct; 43(1):10-9. PubMed ID: 18672073
[TBL] [Abstract][Full Text] [Related]
11. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6.
Schulz JB; Borkert J; Wolf S; Schmitz-Hübsch T; Rakowicz M; Mariotti C; Schöls L; Timmann D; van de Warrenburg B; Dürr A; Pandolfo M; Kang JS; Mandly AG; Nägele T; Grisoli M; Boguslawska R; Bauer P; Klockgether T; Hauser TK
Neuroimage; 2010 Jan; 49(1):158-68. PubMed ID: 19631275
[TBL] [Abstract][Full Text] [Related]
12. Gray matter volume deficits in spinocerebellar ataxia: an optimized voxel based morphometric study.
Goel G; Pal PK; Ravishankar S; Venkatasubramanian G; Jayakumar PN; Krishna N; Purushottam M; Saini J; Faruq M; Mukherji M; Jain S
Parkinsonism Relat Disord; 2011 Aug; 17(7):521-7. PubMed ID: 21600833
[TBL] [Abstract][Full Text] [Related]
13. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6.
Reetz K; Costa AS; Mirzazade S; Lehmann A; Juzek A; Rakowicz M; Boguslawska R; Schöls L; Linnemann C; Mariotti C; Grisoli M; Dürr A; van de Warrenburg BP; Timmann D; Pandolfo M; Bauer P; Jacobi H; Hauser TK; Klockgether T; Schulz JB;
Brain; 2013 Mar; 136(Pt 3):905-17. PubMed ID: 23423669
[TBL] [Abstract][Full Text] [Related]
14. Gray and white matter alterations in spinocerebellar ataxia type 7: an in vivo DTI and VBM study.
Alcauter S; Barrios FA; Díaz R; Fernández-Ruiz J
Neuroimage; 2011 Mar; 55(1):1-7. PubMed ID: 21147232
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the cranial nerves and their nuclei in spinocerebellar ataxia type 2 (SCA2).
Gierga K; Bürk K; Bauer M; Orozco Diaz G; Auburger G; Schultz C; Vuksic M; Schöls L; de Vos RA; Braak H; Deller T; Rüb U
Acta Neuropathol; 2005 Jun; 109(6):617-31. PubMed ID: 15906049
[TBL] [Abstract][Full Text] [Related]
16. [Spinocerebellar ataxias type 1 and 2: comparison of clinical, electrophysiological and magnetic resonance evaluation].
Rakowicz M; Zdzienicka E; Poniatowska R; Waliniowska E; Sułek A; Jakubowska T; Niedzielska K; Rola R; Wierzbicka A; Hoffman-Zacharska D; Głazowski C; Jakubczyk T; Niewiadomska M; Zaremba J
Neurol Neurochir Pol; 2005; 39(4):263-275. PubMed ID: 16096942
[TBL] [Abstract][Full Text] [Related]
17. Spinocerebellar ataxia type 2 (SCA2): identification of early brain degeneration in one monozygous twin in the initial disease stage.
Hoche F; Balikó L; den Dunnen W; Steinecker K; Bartos L; Sáfrány E; Auburger G; Deller T; Korf HW; Klockgether T; Rüb U; Melegh B
Cerebellum; 2011 Jun; 10(2):245-53. PubMed ID: 21128038
[TBL] [Abstract][Full Text] [Related]
18. Thalamic involvement in a spinocerebellar ataxia type 2 (SCA2) and a spinocerebellar ataxia type 3 (SCA3) patient, and its clinical relevance.
Rüb U; Del Turco D; Del Tredici K; de Vos RA; Brunt ER; Reifenberger G; Seifried C; Schultz C; Auburger G; Braak H
Brain; 2003 Oct; 126(Pt 10):2257-72. PubMed ID: 12847080
[TBL] [Abstract][Full Text] [Related]
19. Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study.
Guerrini L; Lolli F; Ginestroni A; Belli G; Della Nave R; Tessa C; Foresti S; Cosottini M; Piacentini S; Salvi F; Plasmati R; De Grandis D; Siciliano G; Filla A; Mascalchi M
Brain; 2004 Aug; 127(Pt 8):1785-95. PubMed ID: 15240431
[TBL] [Abstract][Full Text] [Related]
20. New insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado-Joseph disease).
Rüb U; Brunt ER; Deller T
Curr Opin Neurol; 2008 Apr; 21(2):111-6. PubMed ID: 18317266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
